BRIEF-Royalty Pharma - Enters Revolving Credit Agreement On May 22, 2026

Royalty pharma plc

Royalty pharma plc

RPRX

0.00

May 28 (Reuters) - Royalty Pharma PLC RPRX.O:

  • ROYALTY PHARMA - ENTERS REVOLVING CREDIT AGREEMENT ON MAY 22, 2026 - SEC FILING

  • ROYALTY PHARMA - CREDIT AGREEMENT PROVIDES FOR $1.8 BILLION UNSECURED REVOLVING CREDIT FACILITY - SEC FILING

  • ROYALTY PHARMA - REVOLVING CREDIT FACILITY TO MATURE ON MAY 22, 2031 - SEC FILING

Further company coverage: RPRX.O


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.